Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
L-Valine is one of 8 kinds of essential amino acid. It works with other two kinds of high concentration amino acid (isoleucine and leucine) to improve body normal growth, repair tissue, regulate blood glucose and provide with required energy.
Scope of the Report:
L-Valine is an essential amino acid and, along with L-leucine and L-isoleucine, is part of the branched chain of amino acids. The body cannot manufacture L-valine, so it must be acquired via diet or supplementation. L-valine is mainly used in the production of pharmaceutical products and protected intermediates such L-valine methyl ester hydrochloride, Cbz-L-valine, Boc-L-valine. Therefore, pharmaceutical industry is its largest downstream market, which shares 74.88% of the consumption in 2015.
The L-valine industry is highly competitive due to low entry barriers as the industry is less capital intensive and there is no major technology involved.
The worldwide market for L-Valine is expected to grow at a CAGR of roughly 1.9% over the next five years, will reach 150 million US$ in 2024, from 140 million US$ in 2019, according to a new study.
This report focuses on the L-Valine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Ajinomoto
Kyowa Hakko
Evonik
CJ
Fufeng Group
Maidan Biology
Meihua Group
Yichang Sanxia Pharmaceutical
Star Lake Bioscience
Tianjin Tianan
Wellman Bioscience
Jinghai Amino Acid
Bafeng Pharmaceutical
Jiahe Biotech
Luzhou Group
Jirong Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Pharmaceutical Grade
Food Grade
Feed Grade
Other
Market Segment by Applications, can be divided into
Pharmaceutical Industry
Food Industry
Feed Industry
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe L-Valine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of L-Valine, with price, sales, revenue and global market share of L-Valine in 2017 and 2018.
Chapter 3, the L-Valine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the L-Valine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, L-Valine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe L-Valine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Scope of the Report:
L-Valine is an essential amino acid and, along with L-leucine and L-isoleucine, is part of the branched chain of amino acids. The body cannot manufacture L-valine, so it must be acquired via diet or supplementation. L-valine is mainly used in the production of pharmaceutical products and protected intermediates such L-valine methyl ester hydrochloride, Cbz-L-valine, Boc-L-valine. Therefore, pharmaceutical industry is its largest downstream market, which shares 74.88% of the consumption in 2015.
The L-valine industry is highly competitive due to low entry barriers as the industry is less capital intensive and there is no major technology involved.
The worldwide market for L-Valine is expected to grow at a CAGR of roughly 1.9% over the next five years, will reach 150 million US$ in 2024, from 140 million US$ in 2019, according to a new study.
This report focuses on the L-Valine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Ajinomoto
Kyowa Hakko
Evonik
CJ
Fufeng Group
Maidan Biology
Meihua Group
Yichang Sanxia Pharmaceutical
Star Lake Bioscience
Tianjin Tianan
Wellman Bioscience
Jinghai Amino Acid
Bafeng Pharmaceutical
Jiahe Biotech
Luzhou Group
Jirong Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Pharmaceutical Grade
Food Grade
Feed Grade
Other
Market Segment by Applications, can be divided into
Pharmaceutical Industry
Food Industry
Feed Industry
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe L-Valine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of L-Valine, with price, sales, revenue and global market share of L-Valine in 2017 and 2018.
Chapter 3, the L-Valine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the L-Valine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, L-Valine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe L-Valine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
